Latest From Biotech Now

Mesothelioma: Once Hopeless Cancer, on the Verge of Promising Advances


Mesothelioma, the word, (pronounced mez-uh-thee-lee-oh-muh) is often much better known than the illness it represents. The legal issues surrounding this cancer make mesothelioma, the most expensive keyword on Google (while most keywords cost pennies, the keyword mesothelioma can cost over $300 per click). Mesothelioma, the illness, is a cancer that most often affects the lining of the lung or abdomen; it has no cure and treatment options for patients are few. Prognosis is generally considered Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Haves and Have Nots in Biotech Venture Capital


Recent data from the BIO Industry Analysis team tells a story of “haves and have-nots” in US biopharma venture capital. Three key findings were discussed Wednesday at the 14th Annual BIO Investor Forum. The first finding from the recent study is that funding of therapeutic companies is strong for late rounds (Series B and above), but weak for Series A. Although total levels of venture funding have been climbing recently, the majority of the increase is from late rounds. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

“Get to Know” More About Land, Soil and GMOs

GMO Answers

Throughout this month we’ve invited you to get to know more about GMOs, how the technology has evolved, to sustainable agricultural practices to the balancing act between producing food and protecting pollinators. In week four, we’re focusing on “Land, Soil, Sustainability.” The availability of farmland is essential to agricultural production. Land use and soil health play a critical role in sustainable agriculture…In order for land to be used for agriculture, it must first be suitable Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Investor Forum Closes with Record Attendance


The 14th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all previous attendance and participation records. The energy and buzz around #BIF15 is another sign of the continued strength and resilience of the biotech industry. This year’s forum brought together over 900 registered attendees and 175 presenting companies, facilitating 1700 meetings between investors and senior management for emerging and established biotechnology companies. Scott Whitaker, President of the BIO International Convention and Read More >

Events  |  Leave a comment  |  Email This Post

Fireside Chat: “Everything we knew in science 10 years ago is wrong.”


The speed of scientific innovation these days is comparable to the PC innovation era of the 1980s, according to Robert Nelsen of ARCH Venture Partners at today’s BIO Investor Forum fireside chat. This is not to say that he feels investing in biopharma is a short term game. Robert urged the audience to “keep their faith” in good science and the “good ideas will percolate up” to yield innovative breakthroughs. Having played a significant role Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,